Back to today’s briefing

Story perspectives

Boston Scientific to Acquire Nalu Medical for $533 Million

10/18/2025

39 7 Full Breakdown

Summary

Story summary

Boston Scientific Corporation will acquire Nalu Medical for about $533 million to expand its chronic pain offerings.
Nalu's Neurostimulation System uses peripheral nerve stimulation to treat pain in the shoulder and lower back.
The device is controlled via a smartphone app and received clearance from the U.S. Food and Drug Administration (FDA) in 2019.
Boston Scientific expects $60 million in 2025 sales from Nalu, with over 25% growth in 2026.

1 of 1

Story summary

Boston Scientific Corporation will acquire Nalu Medical for about $533 million to expand its chronic pain offerings.
Nalu's Neurostimulation System uses peripheral nerve stimulation to treat pain in the shoulder and lower back.
The device is controlled via a smartphone app and received clearance from the U.S. Food and Drug Administration (FDA) in 2019.
Boston Scientific expects $60 million in 2025 sales from Nalu, with over 25% growth in 2026.